Compare PRTA & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTA | JBSS |
|---|---|---|
| Founded | 2012 | 1959 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 539.9M | 927.1M |
| IPO Year | 2013 | 1994 |
| Metric | PRTA | JBSS |
|---|---|---|
| Price | $9.95 | $82.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $19.00 | ★ $109.00 |
| AVG Volume (30 Days) | ★ 508.2K | 51.4K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.12 |
| Revenue | $814,000.00 | ★ $1,107,246,000.00 |
| Revenue This Year | $1,111.38 | $5.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.33 |
| Revenue Growth | N/A | ★ 3.79 |
| 52 Week Low | $4.32 | $59.07 |
| 52 Week High | $11.69 | $85.15 |
| Indicator | PRTA | JBSS |
|---|---|---|
| Relative Strength Index (RSI) | 60.70 | 67.73 |
| Support Level | $9.69 | $61.26 |
| Resistance Level | $10.37 | $85.15 |
| Average True Range (ATR) | 0.39 | 2.57 |
| MACD | 0.11 | 0.71 |
| Stochastic Oscillator | 92.81 | 89.80 |
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.
John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.